Reducing mGlu5 expression in ALS SOD1G93A mice by crossing the animals with mice heterozygous for the mGlu5 knockout mutation (Grm5+/−) has been shown to delay disease onset and prolong survival. This evidence concerns the gene GRM5 and amyotrophic lateral sclerosis.